development of the haematopoietic and immune systems development and disease mechanisms nov 11th...

40
Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1. Embryonic origins 2. Bone marrow transplantation as a paridigm for generating an organ from stem cells 3. Mechanisms of stem cell renewal and differentiation 4. Specific examples of erythrocyte and lymphocyte development

Upload: camron-mckenzie

Post on 16-Dec-2015

220 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Development of the Haematopoietic and Immune

Systems

Development and Disease Mechanisms

Nov 11th 2004, Lecture 12

Gerald Crabtree

1. Embryonic origins2. Bone marrow transplantation as a

paridigm for generating an organ from stem cells

3. Mechanisms of stem cell renewal and differentiation

4. Specific examples of erythrocyte and lymphocyte development

Page 2: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone
Page 3: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Overview of Environment of Embryo/FetusExtra embryonic membranes

Page 4: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

The Developmental Origin of Blood and

Immune Cells

• Earliest Site of Haematopoiesis is the Yolk Sac (2-3 weeks) and Dorsal Aorta (AGM region) around 3-5 weeks after conception.

• Yolk sac stem cells are not able to supply all the blood cell type.

• True haematopoietic stem cells appear in the liver at about 6 weeks post conception

Page 5: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Yolk sac, transient extra-embryonic structure –

initiation of blood/Hb synthesis

Page 6: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone
Page 7: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Bone Marrow Transplantation:Creating an Organ from a Stem Cell

• 20,000 bone marrow transplantations per year in the US

• Most commonly used for treatment of malignancy• Also used for treatment of aplastic anemia,

autoimmune disorders, myleodysplastic syndromes (bone marrow failure) and exposure to toxins or radiation.

• Rely on the ability of a small number of Haematopoietic Stem Cells (HSC) to repopulate the immune and hematopoietic systems

Page 8: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

The Atomic Age dawned at 5:29:45 am on July 16, 1945, at Trinity Site, New Mexico

Page 9: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

The Discovery of Stem Cells

Lethal Irradiation

Transfusion of blood or bone marrow from a

normal donor

Death due to anemia,granulocytopenia andthrombocytopenia

Lethal IrradiationSurvival of a significant

number of irradiated individuals

What does blood or bone marrow have that allows the survival of irradiated individuals and the appearance

Of white cells, red cells and platalets?

Page 10: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Reconstitution of the Entire Haematopoietic System by Bone

Marrow Transplantation

Transfusion of blood or bone marrow from a

normal donorLethal Irradiation or Lethal ChemotherapyTo kill all malignant cells

Death of tumor cells And survival of patient

40,000 bone marrow transplantations in 1998General Reference:F. Appelbaum Annu. Rev. Med. 2003. 54:491–512

Donor Provides: Red cells, platelets, white cells, pulmonary alveolar macrophages, Kupffer cells of the liver, osteoclasts, Langerhans cells of the skin, and microglial cells of the brain

Page 11: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Can HSCs give rise to other cell types?

• Early reports indicated that muscle, neurons, hepatocytes and cardiac muscle might derive from adult HSC.

• More recent reports suggests that HSC fuse with other cell types and hence acquired their markers– Science 297, 2256, 2003

A

A

Page 12: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Experimental Paradigm for Study of Haematopoietic Stem Cells

Page 13: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Many types of cells originate from a single type of haematopoietic stem cell (HSC)

Page 14: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Possible Mechanisms for Maintaining a Stem Cell Population

A. Asymmetric Divisions

B. Symmetric Divisions

C. Locally Directed Divisions (Niche directs differentiation after a symmetrical division)

Page 15: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Pair cell assay: E13.5 cortical culture

P-P

Tuj/LeX (CD15)/DAPI

P-N N-N

Symmetric and Asymmetric Divisions of Neural Stem Cells

Brg Acts Cell-Autonomously to Favor Asymmetric Divisions

Lex (CD15) Stem cell markerTuj Differentiated Marker

Page 16: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Maintaining Long Term Haematopoietic Stem Cells: A Major

Unsolved Therapeutic Goal

• Soluble factors that maintain HSCs:– SIF, Flt3L, Tpo, IL-3– Wnt, Notch and Sonic Hedgehog (Shh)

• Transcription factors that increase the replication of HSC– HoxB4 and A9

Possible problems: 1) In vitro creation of a stem cell niche 2) Telemeric shortening with sequential passage in culture;

Under the best of circumstances stem cell reconstitution can only be sustained for 1 or 2 mouse passages

Page 17: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Chromosomal Telemeres Shorten with Passage through the Cell Division Cycle

A possible limitation to the sequential passage of haematopoietic stem cells (HSC)

Elizabeth BlackburnCell 2001

Page 18: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Implies the existence of stem cells for each class of blood cell

The Discovery of Colony Forming Units Demonstrates Self Renewal within Lineages

Page 19: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Sequential Steps of Blood Cell Development are Directed by Cytokines

Page 20: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Sequential Steps of Blood Cell Development are Directed by Cytokines

Cytokine A Cytokine B Cytokine C

CommittedStem Cell

Differentiated and Functional blood cell

Page 21: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Instructive Vs Selective Mechanisms of Receptor Action

• (A and B) Selective mechanism in which two different factors (F1 and F2) allow the survival and maturation of lineage-committed progenitors generated by a cell-autonomous mechanism; “X” indicates death of the other progenitors. Erythropoietin

• (C and D) Instructive mechanism in which the factors cause the stem cell to adopt one fate at the expense of others. Glial growth factor and BMP2

Page 22: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Death of an Anthropomorphism:The Instructive Hypothesis of Receptor Action

H. LodishAnd colleagues

Page 23: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

If Cytokines Do not Give Instructive Signals…

Cytokines probably provide permissive signals that are dependent on the developmental history of a cell

_______

Developmental history is reflected by the expression of receptors, signaling

molecules, transcription factors and chromatin accessibility

Page 24: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

The Development of T Lymphocytes and Red Cells

IL# (interleukin general name for haematopoietic growth factors

SDF-1 (stomal cell Derived factor)

FLT-3 or Flk2 (Fems like tryosine kinaseLigand)

SCF (Stem cell factor) the product ofthe White locus effects both neural crestand haematopoietic cell development. Binds C-kit, mutation of which has near identical Phenotype as SCF mutations.

Epo- Erthropoietin

Tpo- thrombopoietic factor

GM-CSF granulocyte macrophage stimulating factor

G-CSF granuloctye stimulating factor

Page 25: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Development of Red Blood Cells

CommonMyeloid Progenitor

• First red cells are produced in the yolk sac. Later red cell production shifts to the liver, spleen and then the bone marrow.

• Feedback control of RBC Production is through Erythropoietin (Epo). – Necessary to prevent death and promote proliferation of committed precursors– Shifts non-committed progenitor cells into the erythroid lineage– Produced in renal tubular epithelial cells and more widely in the growing embryo– Feedback control targets the first committed cell in the erythroid lineage.

Feedback control loop

Page 26: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

What regulates Erythropoietin (Epo) Production?

• Epo is regulated transcriptionally by an regulatory region near the gene

• This regulatory region binds HIF (Hypoxia Induced Factor)

• Hypoxia regulates HIF• HIF also activates VEGF

and induces vasculogenesis- a problem in pregnancy

Semenza G.L.Cell. 2001 Oct 5;107(1):1-3

Page 27: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Hypoxia Prevents Degradation of HIF-1

If HIF-1 Controls Epo, what Controls HIF-1?

PHD = proline hydroxylase

Page 28: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Leadville, CO- The birth defect capital of the

United States• It is with great pride that we invite you

to share Leadville's spectacular scenery with majestic mountains, rushing streams, alpine lakes, wildflowers in vivid colors, and sky so blue it appears retouched. And that doesn't include winter thrills. Leadville was incorporated in 1878 and is the highest incorporated city in the continental United States at 10,152 feet above sea level.

– From the Leadville Chamber of Commerce

• Anemia stimulates HIF and HIF stimulates VEGF and VEGF induces inappropriate angiogenesis and other patterning defects.

Page 29: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Erythropoietin: The Drug

• Erythropoietin is given for intractable anemia• Best for chronic renal disease• Ineffective in some cases of aplastic anemia• Also effective for increasing blood production for

preoperative storage of autologous blood.

Page 30: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Lymphocyte Development

1) The role of a developmental field in lymphocyte specification.

2) Lineage specification in T cells is dependent on chromatin control.

3) Self vs Non-self discriminationis dependent on decoding signal intensity

Key Points

Page 31: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Pax 5 Repression of Notch Shifts Progenitors into the B Cell

LineageCLP (Common Lymphoid Precursor)

B cell T cell

Pax5

Notch Inactive

Pax5 Inactive

Notch Active

M. Busslinger and colleagues

ThymusBone Marrow

Page 32: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Implies stem cells for each class of blood cellHowever T cell colonies are not found in the spleen

Local Factors Influence the Fate of HSC’s

Page 33: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

What defines the field in which T cells develop?

Hox-1.5 essential for thymic development And mice lacking Hox-1.5 have no:ParathyroidThyroidSubmaxillary tissue

WHN (winged Helix Nude or HNF3g) mutant micelack a thymus

DiGeorge Syndrome 22q11.2 microdeletionCongenital heart disease-craniofacial abnormalitiesand thymic aplasia

Page 34: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Molecular Anatomy of the Microdeletion in DiGeorge Syndrome

• Microdeletion of 22q11.2 occurs in 1/4000 births• Tbx gene implicated in congenital heart defects• Basis for thymic aplasia is still unknown

Page 35: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

T Cell Development:How do lymphocytes tolerate self-antigens yet

respond to foreign antigens?

Wnt IL-7 TCRTCR

Thymus

Reasons to Study T Cell DevelopmentA model system for other developmental processes

Understanding autoimmune disease

If we make new organs from embryonic stem cells they will still be rejected unless we can also control lymphocyte development.

Page 36: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Current View of Selection of the Immune Repertoire

Low Avidity Self MHCLow Intensity Signal?

High Avidity Self AntigenBound to self MHCHigh Intensity Signal?

Positive Selection

Differentiation andProliferation of cells able tointeract with self MHC

Negative Selection

Death of self reactive cells

Signal Intensity

DefaultDeath

No Signal

J. Sprent and colleagues

Page 37: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

T Cell Development: Selection of CD4 and CD8 Cells by MHC

1

What directs the expression of CD4 and CD8?

CD4 interacts withMHC class IIAnd is requiredFor CD4 Cells

CD8 interacts withMHC class IAnd is requiredFor CD8 Cells

Page 38: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

ATP-Dependent Chromatin Remodeling Complexes (BAF) and Control T Cell Lineage Committement

CD4 Locus CD8 Locus

Cell. 2002 Nov 27;111(5):621-33.Nature. 2002 Jul 11;418(6894):195-9

BAF and Mi-2 complexes requiredFor both silencing and activationof CD4 and CD8 genes.

Page 39: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Selection of the Immune Repertoire

Page 40: Development of the Haematopoietic and Immune Systems Development and Disease Mechanisms Nov 11th 2004, Lecture 12 Gerald Crabtree 1.Embryonic origins 2.Bone

Bone Marrow Transplantation as a Paradigm of Therapeutics

Based on Understanding Human Developmental

• Endocrine pancreas• Skin• Bone• Joint surface and articular cartilage• Kidney• Liver• Lung• Heart• Eye• Brain???